Monographie - Pentostatin

Pentostatin

Kemiallinen rakenne

Kauppanimi

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Nipent

Espanja, Hollanti, Irlanti, Iso-Britannia, Italia, Kreikka, New Zealand, Portugali, Ranska, Saksa, Slovenia, Yhdysvallat

Viitteet : Pentostatin

	tyyppi	julkaisu
154	Lehti	Al-Razzak LA, Benedetti AE, Waugh WN, Stella VJ. Chemical stability of pentostatin (NSC-218321), a cytotoxic and immunosuppressant agent. Pharm Res 1990 ; 7: 452-460.
169	Lehti	Trissel LA, Martinez JF. Physical compatibility of melphalan with selected drugs during simulated Y-site administration. Am J Hosp Pharm 1993 ; 50: 2359-2363.
248	Lehti	Trissel LA, Martinez JF. Turbidimetric assessment of the compatibility of taxol with 42 other drugs during simulated Y-site injection. Am J Hosp Pharm 1993 ; 50: 300-304.
334	Lehti	Trissel LA, Tramonte SM, Grilley BJ. Visual compatibility of ondansetron hydrochloride with selected drugs during simulated Y-site injection. Am J Hosp Pharm 1991 ; 48: 988-992.
335	Lehti	Trissel LA, Bready BB, Kwan JW, Santiago NM. Visual compatibility of sargramostim with selected antineoplasic agents, anti-infectives, or other drugs during simulated Y-site injection. Am J Hosp Pharm 1992 ; 49: 402-406.
492	Lehti	Trissel LA, Parks NPT, Santiago NM. Visual compatibility of fludarabine phosphate with antineoplastic drugs, anti-infectives, and other selected drugs during simulated Y-site injection. Am J Hosp Pharm 1991 ; 48: 2186-2189.